Because individuals who have the APOE e4 gene variant appear to have a larger chance of serious problems, the FDA suggests currently being tested with the gene variant before beginning treatment with lecanemab or donanemab. Learn more Empowering far better overall health by diagnostic insights We’re encouraging Group health facilities https://cognitivetestsfordementia33221.blogs-service.com/65277647/not-known-details-about-mild-cognitive-impairment-treatment